Article

Racial differences in genomic features and new trans-ancestry prognosis subtypes in bladder cancer

2021-12-27

Abstract excerpt

<title>Abstract</title> <p>The incidence and survival of bladder cancer vary greatly among different populations but the influence of the associated molecular features and evolutionary processes on its clinical treatment and prognostication remains unknown. Here, we analyze the genomic architectures of over 500 bladder cancer patients from Asian/Black/White populations. We identify novel association between AHNAK...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c882f897-6dfe-5d4b-9d8a-5853e7886796
DOI: 10.21203/rs.3.rs-1157888/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Racial differences in genomic features and new trans-ancestry prognosis subtypes in bladder cancerDOI 10.21203/rs.3.rs-1157888/v1Read

Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer.Semantic proximity Read

Molecular Profiling of Bladder Adenocarcinoma Using a National Genomics RepositorySemantic proximity Read

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responseSemantic proximity Read

APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databasesSemantic proximity Read

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†.Semantic proximity Read

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry.Semantic proximity Read

Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapySemantic proximity Read

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responseSemantic proximity Read

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-upSemantic proximity Read

Mutational Context and Diverse Clonal Development in Early and Late Bladder CancerSemantic proximity Read

Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma.Semantic proximity Read

Bladder Cancer in the Genomic EraSemantic proximity Read